Business Trip
By Greg Kubin & Matias Serebrinsky
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Greg Kubin & Matias Serebrinsky
Category: Mental Health
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 2
Reviews: 0
Episodes: 66
Description
Business Trip explores the frontiers of brain and mental health through conversations with founders, investors, and researchers at the intersection of neuroscience and technology.
| Episode | Date |
|---|---|
|
How Gilgamesh Landed a $1.2B AbbVie Deal in Psychedelics
|
Mar 25, 2026 |
|
Inside Philanthropy’s Role in Mental & Brain Health
|
Jan 27, 2026 |
|
Rick Perry on paving the way for Ibogaine in America
|
Dec 19, 2025 |
|
Brain Shuttles: A New Path Into the Brain with James Gorman of the Wyss Institute
|
Nov 24, 2025 |
|
AI and the future of therapy with Luis Voloch of Jimini Health
|
Oct 16, 2025 |
|
Startups, philanthropy, billionaires, academia, neuromodulation, psychedelics, AI and new therapies in bipolar, autism, and Parkinson’s with Rob Malenka
|
Sep 23, 2025 |
|
Transforming Skin Cells into Neurons to Treat Alzheimer’s with Brendon Boot of Skin2Neuron
|
Aug 21, 2025 |
|
Mitochondria and the Future of Health with Natalie Yivgi-Ohana of Minovia
|
Jul 22, 2025 |
|
The 4-Hour Sleepers Redefining Human Limits with Ying-Hui Fu of UCSF
|
Jun 26, 2025 |
|
What's wrong with US healthcare and how startups can fix it, with Justin Mares
|
Apr 17, 2025 |
|
Temporal Interference: The Future of Brain Stimulation with Nir Grossman
|
Jan 30, 2025 |
|
The State of Autism Part 2 with James Adams of Gut-Brain-Axis Therapeutics Inc.
|
Dec 26, 2024 |
|
The State of Autism Part 1 with Elizabeth Horn of 2m Foundation
|
Dec 12, 2024 |
|
Genetic Medicine for Brain Health with Dana Watt of Breakout Ventures
|
Nov 14, 2024 |
|
Transcranial Focused Ultrasound for Mental Health with Jay Sanguinetti of Sanmai
|
Sep 05, 2024 |
|
Navigating FDA clinical trials in Neurotech with Tim Marjenin
|
Aug 23, 2024 |
|
Environmental Toxins and Mental Health with Gurdane Bhutani
|
Jul 18, 2024 |
|
FDA advisors say no to MDMA. What’s the impact? With Josh Hardman
|
Jun 21, 2024 |
|
Investing in New Frontiers of Mental Health (Live at SXSW)
|
May 07, 2024 |
|
Comparing Psychedelic Compounds in Therapy (Live Panel at Battery SF)
|
Apr 09, 2024 |
|
What Payers Want with Lili Brillstein
|
Mar 14, 2024 |
|
Decoding the Brain with Ed Boyden
|
Feb 22, 2024 |
|
5-MeO-DMT in mental healthcare with Steve Rio
|
Jan 25, 2024 |
|
Tom Insel: Startups, AI, Psychedelics, and SSRIs
|
Dec 15, 2023 |
|
Food as Medicine for Mental Health: Drew Ramsey
|
Nov 30, 2023 |
|
Ketogenic Diet for Brain Health: Jan Baszucki
|
Nov 16, 2023 |
|
Investing in Neurotech 101: Alex Morgan of Khosla Ventures
|
Nov 02, 2023 |
|
All you need is d̶r̶u̶g̶s̶ energy: Motif Neurotech's Implants for Depression
|
Oct 20, 2023 |
|
Holy poop! Mental health and the gut (part 2 with Bloom Science)
|
Sep 28, 2023 |
|
Holy poop! Mental health and the gut (part 1 with Holobiome)
|
Sep 14, 2023 |
|
Ketamine for OCD: Carolyn Rodriguez (Stanford pt 3)
|
Aug 24, 2023 |
|
Are psychedelics effective under anesthesia?: Boris Heifets (Stanford pt 2)
|
Aug 17, 2023 |
|
The Startup Landscape for Expanding Consciousness
|
Aug 09, 2023 |
|
Stanford Psychedelic Overview: Robert Malenka (Stanford pt 1)
|
Jul 20, 2023 |
|
Live from Psychedelic Science 2023
|
Jul 07, 2023 |
|
What VCs Look for in Psychedelic Companies
|
Jun 09, 2023 |
|
Developing Non-Hallucinogenic Psychedelics: Bryan Roth
|
May 15, 2023 |
|
Behind the Scenes of PsyMed Ventures
|
Apr 14, 2023 |
|
The 2023 Psychedelic Industry Landscape with Psychedelic Alpha
|
Feb 27, 2023 |
|
The State of Psychedelics (Part 2): Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)
|
Jan 18, 2023 |
|
The quest to improve MDMA
|
Dec 20, 2022 |
|
Transcranial magnetic stimulation (TMS) paired with ketamine: inside a clinic offering a frontier treatment
|
Nov 29, 2022 |
|
Perspectives from Christian Angermayer, investor and founder in psychedelics
|
Oct 27, 2022 |
|
Soltara: an ethical and profitable ayahuasca retreat
|
Sep 14, 2022 |
|
Microdosing (part 3): The path to FDA approval w/ MindMed and Diamond Therapeutics
|
Aug 16, 2022 |
|
Microdosing (part 2): Placebo is a hell of a drug with Balázs Szigeti
|
Aug 10, 2022 |
|
Microdosing (part 1): James Fadiman and the fundamentals of microdosing
|
Aug 03, 2022 |
|
How the DEA and FDA will regulate psychedelic medicine
|
Jun 24, 2022 |
|
The state of psychedelics: Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)
|
Jun 05, 2022 |
|
Empowering the next wave of psychedelic therapists: Journey Clinical
|
May 23, 2022 |
|
Osmind and the future of electronic health records in psychedelic medicine
|
Apr 18, 2022 |
|
Palo Santo on investing in 2nd gen psychedelics and public markets
|
Mar 21, 2022 |
|
Designing psychedelic mindstates, with Mindstate Design Labs
|
Feb 10, 2022 |
|
MAPS PBC, rethinking the pharma business model and MDMA-assisted therapy
|
Nov 24, 2021 |
|
On transformational ketamine therapy and running an integrative psychedelic clinic
|
Oct 28, 2021 |
|
The new frontiers of DMT therapies
|
Oct 06, 2021 |
|
Scaling Psilocybin Therapy: Compass Pathways' Lars Wilde
|
Aug 13, 2021 |
|
Analyzing the atai Life Sciences IPO
|
Jun 10, 2021 |
|
A 30 year journey towards ibogaine approval: Deborah Mash, CEO of DemeRx
|
May 04, 2021 |
|
Clinical trials, media, reciprocity, open science: Founder of The Trip Report, Zach Haigney
|
Mar 16, 2021 |
|
How to (legally) make psychedelic medicine: CEO of Psygen, Danny Motyka
|
Feb 24, 2021 |
|
From serving medicine to company founder: NANA founder Flor Bollini
|
Jan 05, 2021 |
|
Helping psychedelic practitioners through software: Maya Health CEO David Champion
|
Oct 19, 2020 |
|
How to invest in psychedelic companies: Vine Ventures' Founder Ryan Zurrer
|
Sep 17, 2020 |
|
Building a psychedelic media company: DoubleBlind's Shelby Hartman and Madison Margolin
|
Aug 13, 2020 |
|
Dylan Beynon: ketamine-assisted therapy for anxiety and depression
|
Jun 21, 2020 |